Orzax Collagen Peptides
Natural health product licensed in Canada
- Other names
- Orzax Collagen Peptides Hydrolyzed Type I & III Collagen
- Licence holder
- Orzax Inc.
- NPN or DIN-HM
- 80146025
- Status
- Active licence
- Licence date
- 10 December 2025
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.7 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 250 mg | Not calculated |
| Biotine Source : Biotine | 1,000 Microgrammes | Not calculated |
| Collagène hydrolysé Potency : 2,164 mg Glycine | Not specified | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 5 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 100 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 100 mg | Not calculated |
| Collagène hydrolysé Potency : 1,178 mg L-Proline | 9.6 g | Not calculated |
| Collagène hydrolysé Potency : 52 mg L-Tyrosine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 1,012 mg L-Glutamic acid | Not specified | Not calculated |
| Collagène hydrolysé Potency : 105 mg L-Histidine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 166 mg L-Valine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 332 mg L-Serine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 847 mg L-Arginine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 436 mg L-Lysine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 253 mg L-Leucine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 140 mg L-Isoleucine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 838 mg L-Alanine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 61 mg L-Methionine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 288 mg L-Phenylalanine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 515 mg L-Aspartic acid | Not specified | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | maximum: 18 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in collagen formation (to maintain/support healthy bones/cartilage/teeth/(and) gums). Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/cartilage/teeth/(and) gums. Helps in wound healing/(and) connective tissue formation. Helps to form red blood cells. Helps to maintain/support healthy hair/nail/mucous membranes/(and) skin. Helps to maintain/support immune function/the immune system. Helps to maintain/support the body’s ability to metabolize nutrients. Helps with immune function/the immune system. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps manage/in the management of joint pain. Helps reduce joint pain associated with osteoarthritis. Helps reduce osteoarthritis related joint pain. Source of (the essential amino acid) lysine to help in collagen formation/synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80146025
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.